Cardinal Health Inc.’s stock rose 5% Wednesday, after the drug distributor and medical products maker beat estimates for its fiscal fourth quarter and raised its guidance. Dublin, Ohio-based Cardinal ...
Barclays analyst Glen Santangelo initiated coverage of Cardinal Health, Inc. (NYSE:CAH) on December 9, giving the stock an Overweight rating and a $243 price target. The firm started its broader view ...
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback